Fasenra 30 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FQWD7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,938
Award facts
- Contract value 100% obligated
- $24,937.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,937.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Fasenra 30 mg/mL syringes. The delivery order, issued on November 24, 2025, with an ultimate completion date of November 25, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award falls under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which was established on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036.
DMS Pharmaceutical Group serves as a critical regional pharmaceutical supplier within the broader $30.3 billion PPV-G GEN V acquisition strategy, which supports Department of Defense military healthcare facilities worldwide. The company's extensive product portfolio includes branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals, positioning it to fulfill diverse and specialized pharmaceutical requirements for federal military medical operations. The delivery order for Fasenra represents one of numerous awards issued to the contractor by the Defense Logistics Agency's Medical Supply Chain division, reflecting the company's established performance and capability to meet recurring medical supply needs across the federal healthcare system.
Quick answers
Who was awarded contract SPE2DR26FQWD7?
SPE2DR26FQWD7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FQWD7 worth?
The government has obligated $24,938 on SPE2DR26FQWD7.
Is contract SPE2DR26FQWD7 an order under another contract?
Yes. SPE2DR26FQWD7 is a delivery order under SPE2DR25D9353, an indefinite delivery contract.
Was contract SPE2DR26FQWD7 competed?
The extent of competition for SPE2DR26FQWD7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award